versiti
Dec 12, 2025, 06:35
Genotyping More Than 300,000 Blood Donors by Versiti
Versiti Blood Research Institute shared a post on LinkedIn:
“Incredible work by our colleagues across Versiti! This case is a powerful example of how decades of scientific investment (in this case, genotyping more than 300,000 blood donors) translates directly into lifesaving patient outcomes.”
Quoting Versiti Inc.’s post:
“In response to an urgent request from a major West Coast medical center, the National Blood Exchange reached out across member facilities, asking if any of them could quickly address a critical need for a patient. Versiti answered the call.
Read the full story.”
Follow the latest in Hemostasis Today.
-
Oct 7, 2026, 16:44Amor Salah: 2026 NCS/SCCM Guidelines for Managing Antithrombotic-Associated ICH
-
Oct 7, 2026, 16:04NETs in Thrombosis: From Mechanism to Therapeutic Target
-
Oct 7, 2026, 15:28Amir Samimi: Prognostic Value of Platelet Count in Resected HNSCC
-
Oct 7, 2026, 15:21Eloïse Laouenan: Bridging Immunity and Thrombosis in MVTE
-
Oct 7, 2026, 15:10Uthra Sundaram: Honouring Donors During International Plasma Awareness Week
-
Oct 7, 2026, 15:04Daniel Victor Ortigoza: Should Frail Older Patients With AF Switch From VKA to DOACs?
-
Oct 7, 2026, 14:53Susan Noone: Donor Turned Recipient Shares Lifesaving Transfusion Story
-
Oct 7, 2026, 14:49Aimee Burtenshaw: The Impact of the Infected Blood Inquiry on Hospital Transfusion Laboratories
-
Oct 7, 2026, 14:41Vikash Jaiswal: Does Timing Matter for Calcium in Pre-Eclampsia Prevention?